Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.

Salvage treatment and survival for relapsed follicular lymphoma following primary radiotherapy: A collaborative study on behalf of ILROG.

Binkley MS, Brady JL, Hajj C, Chelius M, Chau K, Balogh A, Levis M, Filippi AR, Jones M, Ahmed S, MacManus M, Wirth A, Oguchi M, Vistisen AK, Andraos TY, Ng A, Aleman BMP, Choi SH, Kirova Y, Hardy S, Reinartz G, Eich H, Bratman S, Constine LS, Suh CO, Dabaja B, El-Galaly T, Hodgson D, Ricardi U, Yahalom J, Mikhaeel NG, Hoppe RT.

Int J Radiat Oncol Biol Phys. 2019 Mar 8. pii: S0360-3016(19)30317-7. doi: 10.1016/j.ijrobp.2019.03.004. [Epub ahead of print]

PMID:
30858143
2.

The optimal use of imaging in Radiation Therapy for lymphoma - Guidelines from the International Lymphoma Radiation Oncology Group (ILROG).

Mikhaeel NG, Milgrom SA, Terezakis S, Berthelsen AK, Hodgson D, Eich HT, Dieckmann K, Qi SN, Yahalom J, Specht L.

Int J Radiat Oncol Biol Phys. 2019 Feb 11. pii: S0360-3016(19)30191-9. doi: 10.1016/j.ijrobp.2019.02.001. [Epub ahead of print] Review.

PMID:
30763664
3.

Langerhans cell histiocytosis in adults is associated with a high prevalence of hematologic and solid malignancies.

Ma J, Laird JH, Chau KW, Chelius MR, Lok BH, Yahalom J.

Cancer Med. 2019 Jan;8(1):58-66. doi: 10.1002/cam4.1844. Epub 2018 Dec 30.

4.

Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a collaborative study by ILROG.

Brady JL, Binkley MS, Hajj C, Chelius M, Chau K, Balogh A, Levis M, Filippi AR, Jones M, Mac Manus M, Wirth A, Oguchi M, Vistisen AK, Andraos TY, Ng AK, Aleman BMP, Choi SH, Kirova Y, Hardy S, Reinartz G, Eich HT, Bratman SV, Constine LS, Suh CO, Dabaja B, El-Galaly TC, Hodgson DC, Ricardi U, Yahalom J, Hoppe RT, Mikhaeel NG.

Blood. 2019 Jan 17;133(3):237-245. doi: 10.1182/blood-2018-04-843540. Epub 2018 Nov 16.

PMID:
30446493
5.

Low-Dose Radiation Conditioning Enables CAR T Cells to Mitigate Antigen Escape.

DeSelm C, Palomba ML, Yahalom J, Hamieh M, Eyquem J, Rajasekhar VK, Sadelain M.

Mol Ther. 2018 Nov 7;26(11):2542-2552. doi: 10.1016/j.ymthe.2018.09.008. Epub 2018 Sep 13.

PMID:
30415658
6.

Lymphoblastic Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group (ILROG).

Dabaja BS, Specht L, Yahalom J.

Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):508-514. doi: 10.1016/j.ijrobp.2018.05.078. Epub 2018 Jun 7. Review.

PMID:
30238900
7.

Use of Radiation in Extramedullary Leukemia/Chloroma: Guidelines From the International Lymphoma Radiation Oncology Group.

Bakst RL, Dabaja BS, Specht LK, Yahalom J.

Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):314-319. doi: 10.1016/j.ijrobp.2018.05.045. Epub 2018 May 29. Review.

PMID:
30191865
8.

Early-Stage Follicular Lymphoma: What Is the Preferred Treatment Strategy?

Yang JC, Yahalom J.

J Clin Oncol. 2018 Oct 10;36(29):2904-2906. doi: 10.1200/JCO.2018.79.3075. Epub 2018 Aug 28. No abstract available.

PMID:
30153098
9.

Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines.

Dabaja BS, Hoppe BS, Plastaras JP, Newhauser W, Rosolova K, Flampouri S, Mohan R, Mikhaeel NG, Kirova Y, Specht L, Yahalom J.

Blood. 2018 Oct 18;132(16):1635-1646. doi: 10.1182/blood-2018-03-837633. Epub 2018 Aug 14. Review.

10.

Radiation in Central Nervous System Leukemia: Guidelines From the International Lymphoma Radiation Oncology Group.

Pinnix CC, Yahalom J, Specht L, Dabaja BS.

Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):53-58. doi: 10.1016/j.ijrobp.2018.05.067. Epub 2018 Jun 6. Review. No abstract available.

PMID:
30102203
11.

Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group.

Tsang RW, Campbell BA, Goda JS, Kelsey CR, Kirova YM, Parikh RR, Ng AK, Ricardi U, Suh CO, Mauch PM, Specht L, Yahalom J.

Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):794-808. doi: 10.1016/j.ijrobp.2018.05.009. Epub 2018 Jun 20. Review.

PMID:
29976492
12.

Outcomes of Relapsed and Refractory Primary Mediastinal (Thymic) Large B Cell Lymphoma Treated with Second-Line Therapy and Intent to Transplant.

Vardhana S, Hamlin PA, Yang J, Zelenetz A, Sauter CS, Matasar MJ, Ni A, Yahalom J, Moskowitz CH.

Biol Blood Marrow Transplant. 2018 Oct;24(10):2133-2138. doi: 10.1016/j.bbmt.2018.06.009. Epub 2018 Jun 15.

PMID:
29909154
13.

Total Body Irradiation: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG).

Wong JYC, Filippi AR, Dabaja BS, Yahalom J, Specht L.

Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):521-529. doi: 10.1016/j.ijrobp.2018.04.071. Epub 2018 May 2. Review.

PMID:
29893272
14.

Treatment of Vulvar Mycosis Fungoides Tumors With Localized Radiotherapy.

Geller S, Pitter K, Moskowitz A, Horwitz SM, Yahalom J, Myskowski PL.

Clin Lymphoma Myeloma Leuk. 2018 Jul;18(7):e279-e281. doi: 10.1016/j.clml.2018.04.010. Epub 2018 May 4. No abstract available.

PMID:
29752211
15.

The Role of Radiation Therapy in Patients With Relapsed or Refractory Hodgkin Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group.

Constine LS, Yahalom J, Ng AK, Hodgson DC, Wirth A, Milgrom SA, Mikhaeel NG, Eich HT, Illidge T, Ricardi U, Dieckmann K, Moskowitz CH, Advani R, Mauch PM, Specht L, Hoppe RT.

Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1100-1118. doi: 10.1016/j.ijrobp.2018.01.011. Epub 2018 Jan 9. Review.

PMID:
29722655
16.

Uptake of [18F]fluorodeoxyglucose in initial positron-emission tomography predicts survival in MALT lymphoma.

Qi S, Huang MY, Yang Y, Schöder H, Teckie S, Noy A, Chau K, Yahalom J.

Blood Adv. 2018 Mar 27;2(6):649-655. doi: 10.1182/bloodadvances.2017013698.

17.

NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018.

Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Armand P, Bello CM, Benitez CM, Bierman PJ, Chen R, Dabaja B, Dean R, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Huang J, Johnston PB, Kaminski MS, Kenkre VP, Khan N, Maddocks K, Maloney DG, Metzger M, Moore JO, Morgan D, Moskowitz CH, Mulroney C, Rabinovitch R, Seropian S, Tao R, Winter JN, Yahalom J, Burns JL, Ogba N.

J Natl Compr Canc Netw. 2018 Mar;16(3):245-254. doi: 10.6004/jnccn.2018.0013.

PMID:
29523663
18.

Outcome After Radiation Therapy for Langerhans Cell Histiocytosis Is Dependent on Site of Involvement.

Laird J, Ma J, Chau K, Chelius M, Shi W, Zhang Z, Lok BH, Yahalom J.

Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):670-678. doi: 10.1016/j.ijrobp.2017.10.053. Epub 2017 Nov 6.

19.

Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group.

Ng AK, Yahalom J, Goda JS, Constine LS, Pinnix CC, Kelsey CR, Hoppe B, Oguchi M, Suh CO, Wirth A, Qi S, Davies A, Moskowitz CH, Laskar S, Li Y, Mauch PM, Specht L, Illidge T.

Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):652-669. doi: 10.1016/j.ijrobp.2017.12.005. Review.

PMID:
29413279
20.

NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018.

Kumar SK, Callander NS, Alsina M, Atanackovic D, Biermann JS, Castillo J, Chandler JC, Costello C, Faiman M, Fung HC, Godby K, Hofmeister C, Holmberg L, Holstein S, Huff CA, Kang Y, Kassim A, Liedtke M, Malek E, Martin T, Neppalli VT, Omel J, Raje N, Singhal S, Somlo G, Stockerl-Goldstein K, Weber D, Yahalom J, Kumar R, Shead DA.

J Natl Compr Canc Netw. 2018 Jan;16(1):11-20. doi: 10.6004/jnccn.2018.0002.

PMID:
29295877
21.

Solitary Extramedullary Plasmacytoma of the Cricoid Cartilage-Case Report.

Krebs S, Ganly I, Ghossein R, Yang J, Yahalom J, Schöder H.

Front Oncol. 2017 Nov 27;7:284. doi: 10.3389/fonc.2017.00284. eCollection 2017.

22.

Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma.

Moskowitz AJ, Schöder H, Gavane S, Thoren KL, Fleisher M, Yahalom J, McCall SJ, Cadzin BR, Fox SY, Gerecitano J, Grewal R, Hamlin PA, Horwitz SM, Kumar A, Matasar M, Ni A, Noy A, Palomba ML, Perales MA, Portlock CS, Sauter C, Straus D, Younes A, Zelenetz AD, Moskowitz CH.

Blood. 2017 Nov 16;130(20):2196-2203. doi: 10.1182/blood-2017-06-788877. Epub 2017 Sep 5.

23.

In Reply to Zhang.

Parikh RR, Grossbard ML, Harrison LB, Yahalom J.

Int J Radiat Oncol Biol Phys. 2017 Oct 1;99(2):501. doi: 10.1016/j.ijrobp.2017.04.038. No abstract available.

PMID:
28872005
24.

Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.

Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Benitez CM, Bernat K, Bierman PJ, Blum KA, Chen R, Dabaja B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Huang J, Johnston PB, Kaminski MS, Kenkre VP, Khan N, Maloney DG, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Mulroney C, Poppe M, Rabinovitch R, Seropian S, Smith M, Winter JN, Yahalom J, Burns J, Ogba N, Sundar H.

J Natl Compr Canc Netw. 2017 May;15(5):608-638.

PMID:
28476741
25.

Accelerated Total Lymphoid Irradiation-containing Salvage Regimen for Patients With Refractory and Relapsed Hodgkin Lymphoma: 20 Years of Experience.

Rimner A, Lovie S, Hsu M, Chelius M, Zhang Z, Chau K, Moskowitz AJ, Matasar M, Moskowitz CH, Yahalom J.

Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):1066-1076. doi: 10.1016/j.ijrobp.2017.01.222. Epub 2017 Feb 1.

26.

NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2017.

Wierda WG, Zelenetz AD, Gordon LI, Abramson JS, Advani RH, Andreadis CB, Bartlett N, Byrd JC, Caimi P, Fayad LE, Fisher RI, Glenn MJ, Habermann TM, Harris NL, Hernandez-Ilizaliturri F, Hoppe RT, Horwitz SM, Kaminski MS, Kelsey CR, Kim YH, Krivacic S, LaCasce AS, Martin MG, Nademanee A, Porcu P, Press O, Rabinovitch R, Reddy N, Reid E, Roberts K, Saad AA, Snyder ED, Sokol L, Swinnen LJ, Vose JM, Yahalom J, Dwyer MA, Sundar H.

J Natl Compr Canc Netw. 2017 Mar;15(3):293-311.

PMID:
28275031
27.

Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology.

Kumar SK, Callander NS, Alsina M, Atanackovic D, Biermann JS, Chandler JC, Costello C, Faiman M, Fung HC, Gasparetto C, Godby K, Hofmeister C, Holmberg L, Holstein S, Huff CA, Kassim A, Liedtke M, Martin T, Omel J, Raje N, Reu FJ, Singhal S, Somlo G, Stockerl-Goldstein K, Treon SP, Weber D, Yahalom J, Shead DA, Kumar R.

J Natl Compr Canc Netw. 2017 Feb;15(2):230-269.

PMID:
28188192
28.

Curative radiation for orbital MZL: how much?

Yahalom J.

Blood. 2017 Jan 19;129(3):270-271. doi: 10.1182/blood-2016-11-749176. No abstract available.

29.

Challenges and opportunities in primary CNS lymphoma: A systematic review.

Kerbauy MN, Moraes FY, Lok BH, Ma J, Kerbauy LN, Spratt DE, Santos FP, Perini GF, Berlin A, Chung C, Hamerschlak N, Yahalom J.

Radiother Oncol. 2017 Mar;122(3):352-361. doi: 10.1016/j.radonc.2016.12.033. Epub 2017 Jan 16. Review.

PMID:
28104300
30.

Risk factors predicting outcomes for primary refractory hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantation.

Shah GL, Yahalom J, Matasar MJ, Verwys SL, Goldman DA, Bantilan KS, Zhang Z, McCall SJ, Moskowitz AJ, Moskowitz CH.

Br J Haematol. 2016 Nov;175(3):440-447. doi: 10.1111/bjh.14245. Epub 2016 Jul 5.

31.

Older patients with early-stage diffuse large B-cell lymphoma: the role of consolidation radiotherapy after chemoimmunotherapy.

Parikh RR, Yahalom J.

Leuk Lymphoma. 2017 Mar;58(3):614-622. doi: 10.1080/10428194.2016.1205739. Epub 2016 Aug 9.

PMID:
27685446
32.

NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016.

Horwitz SM, Zelenetz AD, Gordon LI, Wierda WG, Abramson JS, Advani RH, Andreadis CB, Bartlett N, Byrd JC, Fayad LE, Fisher RI, Glenn MJ, Habermann TM, Lee Harris N, Hernandez-Ilizaliturri F, Hoppe RT, Kaminski MS, Kelsey CR, Kim YH, Krivacic S, LaCasce AS, Lunning M, Nademanee A, Press O, Rabinovitch R, Reddy N, Reid E, Roberts K, Saad AA, Sokol L, Swinnen LJ, Vose JM, Yahalom J, Zafar N, Dwyer M, Sundar H, Porcu P.

J Natl Compr Canc Netw. 2016 Sep;14(9):1067-79.

PMID:
27587620
33.

Correction: Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug Combinations.

Yalon M, Tuval-Kochen L, Castel D, Moshe I, Mazal I, Cohen O, Avivi C, Rosenblatt K, Aviel-Ronen S, Schiby G, Yahalom J, Amariglio N, Pfeffer R, Lawrence YR, Toren A, Rechavi G, Paglin S.

PLoS One. 2016 Aug 22;11(8):e0161799. doi: 10.1371/journal.pone.0161799. eCollection 2016.

34.

Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma.

Kumar A, Casulo C, Yahalom J, Schöder H, Barr PM, Caron P, Chiu A, Constine LS, Drullinsky P, Friedberg JW, Gerecitano JF, Hamilton A, Hamlin PA, Horwitz SM, Jacob AG, Matasar MJ, McArthur GN, McCall SJ, Moskowitz AJ, Noy A, Palomba ML, Portlock CS, Straus DJ, VanderEls N, Verwys SL, Yang J, Younes A, Zelenetz AD, Zhang Z, Moskowitz CH.

Blood. 2016 Sep 15;128(11):1458-64. doi: 10.1182/blood-2016-03-703470. Epub 2016 Jul 25.

35.

Definition of bulky disease in early stage Hodgkin lymphoma in computed tomography era: prognostic significance of measurements in the coronal and transverse planes.

Kumar A, Burger IA, Zhang Z, Drill EN, Migliacci JC, Ng A, LaCasce A, Wall D, Witzig TE, Ristow K, Yahalom J, Moskowitz CH, Zelenetz AD.

Haematologica. 2016 Oct;101(10):1237-1243. Epub 2016 Jul 6.

36.

Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug Combinations.

Yalon M, Tuval-Kochen L, Castel D, Moshe I, Mazal I, Cohen O, Avivi C, Rosenblatt K, Aviel-Ronen S, Schiby G, Yahalom J, Amariglio N, Pfeffer R, Lawrence Y, Toren A, Rechavi G, Paglin S.

PLoS One. 2016 May 19;11(5):e0155711. doi: 10.1371/journal.pone.0155711. eCollection 2016. Erratum in: PLoS One. 2016;11(8):e0161799.

37.

Encouraging experience in the treatment of nasal type extra-nodal NK/T-cell lymphoma in a non-Asian population.

Qi S, Yahalom J, Hsu M, Chelius M, Lunning M, Moskowitz A, Horwitz S.

Leuk Lymphoma. 2016 Nov;57(11):2575-83. doi: 10.1080/10428194.2016.1180689. Epub 2016 May 17.

38.

NCCN Guidelines Insights: Multiple Myeloma, Version 3.2016.

Anderson KC, Alsina M, Atanackovic D, Biermann JS, Chandler JC, Costello C, Djulbegovic B, Fung HC, Gasparetto C, Godby K, Hofmeister C, Holmberg L, Holstein S, Huff CA, Kassim A, Krishnan AY, Kumar SK, Liedtke M, Lunning M, Raje N, Reu FJ, Singhal S, Somlo G, Stockerl-Goldstein K, Treon SP, Weber D, Yahalom J, Shead DA, Kumar R.

J Natl Compr Canc Netw. 2016 Apr;14(4):389-400.

39.

Re-Examining the Role of Radiation Therapy for Diffuse Large B-Cell Lymphoma in the Modern Era.

Ng AK, Dabaja BS, Hoppe RT, Illidge T, Yahalom J.

J Clin Oncol. 2016 May 1;34(13):1443-7. doi: 10.1200/JCO.2015.64.9418. Epub 2016 Feb 22. No abstract available.

PMID:
26903576
40.

Diffuse Large B-Cell Lymphoma Version 1.2016.

Zelenetz AD, Gordon LI, Wierda WG, Abramson JS, Advani RH, Andreadis CB, Bartlett N, Byrd JC, Fayad LE, Fisher RI, Glenn MJ, Habermann TM, Lee Harris N, Hernandez-Ilizaliturri F, Hoppe RT, Horwitz SM, Kaminski MS, Kelsey CR, Kim YH, Krivacic S, LaCasce AS, Lunning M, Nademanee A, Porcu P, Press O, Rabinovitch R, Reddy N, Reid E, Roberts K, Saad AA, Sokol L, Swinnen LJ, Vose JM, Yahalom J, Zafar N, Dwyer M, Sundar H.

J Natl Compr Canc Netw. 2016 Feb;14(2):196-231.

PMID:
26850490
41.

Multiple Myeloma, Version 2.2016: Clinical Practice Guidelines in Oncology.

Anderson KC, Alsina M, Atanackovic D, Biermann JS, Chandler JC, Costello C, Djulbegovic B, Fung HC, Gasparetto C, Godby K, Hofmeister C, Holmberg L, Holstein S, Huff CA, Kassim A, Krishnan AY, Kumar SK, Liedtke M, Lunning M, Raje N, Singhal S, Smith C, Somlo G, Stockerl-Goldstein K, Treon SP, Weber D, Yahalom J, Shead DA, Kumar R; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2015 Nov;13(11):1398-435.

42.

Association of intensity-modulated radiation therapy on overall survival for patients with Hodgkin lymphoma.

Parikh RR, Grossbard ML, Harrison LB, Yahalom J.

Radiother Oncol. 2016 Jan;118(1):52-9. doi: 10.1016/j.radonc.2015.10.022. Epub 2015 Oct 29.

PMID:
26522061
43.

Sarcoid in cancer patients: clinical characteristics and associated disease status.

Kiess AP, Wang H, Travis WD, Yahalom J.

Sarcoidosis Vasc Diffuse Lung Dis. 2015 Sep 14;32(3):200-7.

PMID:
26422564
44.

Innovative Approaches to Radiation Treatment for Mycosis Fungoides in the Setting of Collagen Vascular Disease.

Terezakis SA, Bohle GC 3rd, Lo YC, Berry SL, Yahalom J.

Case Rep Oncol Med. 2015;2015:853823. doi: 10.1155/2015/853823. Epub 2015 Aug 27.

45.

Impact of delays in definitive treatment on overall survival: a National Cancer Database study of patients with Hodgkin lymphoma.

Parikh RR, Grossbard ML, Harrison LB, Yahalom J.

Leuk Lymphoma. 2016 May;57(5):1074-82. doi: 10.3109/10428194.2015.1094696. Epub 2015 Oct 15.

PMID:
26374099
46.

Early-Stage Classic Hodgkin Lymphoma: The Utilization of Radiation Therapy and Its Impact on Overall Survival.

Parikh RR, Grossbard ML, Harrison LB, Yahalom J.

Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):684-93. doi: 10.1016/j.ijrobp.2015.06.039. Epub 2015 Jul 6.

PMID:
26279323
47.

The concept and evolution of involved site radiation therapy for lymphoma.

Specht L, Yahalom J.

Int J Clin Oncol. 2015 Oct;20(5):849-54. doi: 10.1007/s10147-015-0863-y. Epub 2015 Jul 7. Review.

PMID:
26150257
48.

Early-stage nodular lymphocyte-predominant Hodgkin lymphoma: the impact of radiotherapy on overall survival.

Parikh RR, Grossbard ML, Harrison LB, Yahalom J.

Leuk Lymphoma. 2016 Feb;57(2):320-327. doi: 10.3109/10428194.2015.1065978. Epub 2015 Oct 2.

49.

Disparities in survival by insurance status in patients with Hodgkin lymphoma.

Parikh RR, Grossbard ML, Green BL, Harrison LB, Yahalom J.

Cancer. 2015 Oct 1;121(19):3515-24. doi: 10.1002/cncr.29518. Epub 2015 Jun 8.

50.

Hodgkin lymphoma, version 2.2015.

Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Benitez CM, Bierman PJ, Blum KA, Chen R, Dabaja B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Huang J, Johnston PB, Khan N, Maloney DG, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Mulroney C, Poppe M, Rabinovitch R, Seropian S, Tsien C, Winter JN, Yahalom J, Burns JL, Sundar H; National comprehensive cancer network.

J Natl Compr Canc Netw. 2015 May;13(5):554-86.

Supplemental Content

Loading ...
Support Center